You asked. We’re on it.
In our last newsletter, we asked a simple question: Should Medsender tackle insurance pre-authorization? And the response was overwhelming: yes, please.
We get it. Pre-auth is a pain.
Whether it’s waiting days for approval or chasing down missing paperwork, preauthorization is one of the slowest, most frustrating steps in the care journey. It delays treatment. It frustrates patients. This creates a bottleneck between clinical decisions and real action - not to mention slowing down revenue.
That’s why we’re building a better way.
Our upcoming pre-authorization feature is designed to:
It’s still in development, but we’re designing it to do what pre-auth rarely does: keep care and cash flow moving.
Because when prior auth stalls, everything stalls - schedules, treatment plans and payments.
We think it’s time for a better way. Stay tuned. We’re working on it.